UDP-Glucosyltransferases,

Yongsong Wu1,2,3,4,5, Ning Xu2,3,4,5,6, Yingying Xue2,3,4,5

  • 1College of Life Science, Dalian Minzu University, Dalian, Liaoning 116600, China.

概括

研究人员开发了一种可持续的微生物平台,用于生产宝贵的制药化合物emodin糖化物. 他们改造了Aspergillus terreus和Escherichia coli,为emodin-6-O-β-d-glucoside (E6G) 和emodin-8-O-β-d-glucoside (E8G) 实现了高标位和转化率.